Search Results

There are 6302 results for: content related to: Inactivation of Vhl in Osteochondral Progenitor Cells Causes High Bone Mass Phenotype and Protects Against Age-Related Bone Loss in Adult Mice

  1. You have free access to this content
    Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis

    Hepatology

    Volume 54, Issue 2, August 2011, Pages: 472–483, Aijuan Qu, Matthew Taylor, Xiang Xue, Tsutomu Matsubara, Daniel Metzger, Pierre Chambon, Frank J. Gonzalez and Yatrik M. Shah

    Version of Record online : 26 JUN 2011, DOI: 10.1002/hep.24400

  2. You have full text access to this OnlineOpen article
    Deletion of the von Hippel–Lindau gene causes sympathoadrenal cell death and impairs chemoreceptor-mediated adaptation to hypoxia

    EMBO Molecular Medicine

    Volume 6, Issue 12, December 2014, Pages: 1577–1592, David Macías, Mary Carmen Fernández-Agüera, Victoria Bonilla-Henao and José López-Barneo

    Version of Record online : 10 NOV 2014, DOI: 10.15252/emmm.201404153

  3. You have full text access to this OnlineOpen article
    Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice

    EMBO Molecular Medicine

    Volume 5, Issue 6, June 2013, Pages: 949–964, Joachim Albers, Michal Rajski, Désirée Schönenberger, Sabine Harlander, Peter Schraml, Adriana von Teichman, Strahil Georgiev, Peter J. Wild, Holger Moch, Wilhelm Krek and Ian J. Frew

    Version of Record online : 22 APR 2013, DOI: 10.1002/emmm.201202231

  4. Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification

    Clinical Genetics

    Volume 72, Issue 2, August 2007, Pages: 122–129, FJ Hes, RB van der Luijt, ALW Janssen, RA Zewald, GJ de Jong, JW Lenders, TP Links, GPM Luyten, RH Sijmons, HJ Eussen, DJJ Halley, CJM Lips, PL Pearson, AMW van den Ouweland and DF Majoor-Krakauer

    Version of Record online : 4 JUL 2007, DOI: 10.1111/j.1399-0004.2007.00827.x

  5. Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma

    Genes, Chromosomes and Cancer

    Volume 53, Issue 1, January 2014, Pages: 38–51, Lucy Gossage, Muhammed Murtaza, Andrew F. Slatter, Conrad P. Lichtenstein, Anne Warren, Beverley Haynes, Francesco Marass, Ian Roberts, Susan J. Shanahan, Andreas Claas, Andrew Dunham, Andrew P. May, Nitzan Rosenfeld, Tim Forshew and Tim Eisen

    Version of Record online : 29 OCT 2013, DOI: 10.1002/gcc.22116

  6. VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma

    The Journal of Pathology

    Volume 196, Issue 2, February 2002, Pages: 186–193, Peter Schraml, Kirsten Struckmann, Florian Hatz, Stefan Sonnet, Charlotte Kully, Thomas Gasser, Guido Sauter, Michael J. Mihatsch and Holger Moch

    Version of Record online : 18 DEC 2001, DOI: 10.1002/path.1034

  7. You have free access to this content
    Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas

    International Journal of Cancer

    Volume 105, Issue 2, 10 June 2003, Pages: 190–195, Hilde Dannenberg, Ronald R. De Krijger, Erwin van der Harst, Mustaffa Abbou, Ynske IJzendoorn, Paul Komminoth and Winand N.M. Dinjens

    Version of Record online : 5 MAR 2003, DOI: 10.1002/ijc.11060

  8. You have free access to this content
    The von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma

    International Journal of Cancer

    Volume 119, Issue 3, 1 August 2006, Pages: 624–629, Jasmien Hoebeeck, Jo Vandesompele, Helén Nilsson, Katleen De Preter, Nadine Van Roy, Els De Smet, Nurten Yigit, Anne De Paepe, Geneviève Laureys, Sven Påhlman and Frank Speleman

    Version of Record online : 27 FEB 2006, DOI: 10.1002/ijc.21888

  9. You have free access to this content
    Systemic VHL gene functions and the VHL disease

    FEBS Letters

    Volume 586, Issue 11, June 04, 2012, Pages: 1562–1569, Hannah L. Bader and Tien Hsu

    Version of Record online : 25 APR 2012, DOI: 10.1016/j.febslet.2012.04.032

  10. You have full text access to this Open Access content
    Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti-angiogenic therapy

    Cancer Science

    Volume 103, Issue 11, November 2012, Pages: 2027–2037, Toshinari Yamasaki, Tomomi Kamba, Toru Kanno, Takahiro Inoue, Noboru Shibasaki, Ryuichiro Arakaki, Tomomi Yamada, Keiichi Kondo, Toshiyuki Kamoto, Hiroyuki Nishiyama, Osamu Ogawa and Eijiro Nakamura

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1349-7006.2012.02412.x

  11. 1H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism

    International Journal of Cancer

    Volume 138, Issue 10, May 15 2016, Pages: 2439–2449, Miroslava Cuperlovic-Culf, Kevin Cormier, Mohamed Touaibia, Julie Reyjal, Sarah Robichaud, Mehdi Belbraouet and Sandra Turcotte

    Version of Record online : 29 JAN 2016, DOI: 10.1002/ijc.29947

  12. You have free access to this content
    Endoplasmic reticulum/cytosolic localization of von Hippel-Lindau gene products is mediated by a 64–amino acid region

    International Journal of Cancer

    Volume 91, Issue 4, 15 February 2001, Pages: 457–467, Alan R. Schoenfeld, Eliot J. Davidowitz and Robert D. Burk

    Version of Record online : 9 MAR 2001, DOI: 10.1002/1097-0215(20010215)91:4<457::AID-IJC1072>3.0.CO;2-P

  13. Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: Relationship to clinicopathological parameters

    Genes, Chromosomes and Cancer

    Volume 34, Issue 1, May 2002, Pages: 58–68, Keiichi Kondo, Masahiro Yao, Minoru Yoshida, Takeshi Kishida, Taro Shuin, Takeshi Miura, Masatoshi Moriyama, Kazuki Kobayashi, Naoki Sakai, Shigeki Kaneko, Satoshi Kawakami, Masaya Baba, Noboru Nakaigawa, Yoji Nagashima, Yukio Nakatani and Masahiko Hosaka

    Version of Record online : 7 FEB 2002, DOI: 10.1002/gcc.10054

  14. Hypoxia-inducible factor 1 activation from adipose protein 2-cre mediated knockout of von hippel-lindau gene leads to embryonic lethality

    Clinical and Experimental Pharmacology and Physiology

    Volume 39, Issue 2, February 2012, Pages: 145–150, Jin Zhang, Yanning Wang, Zhanguo Gao, Zhong Yun and Jianping Ye

    Version of Record online : 30 JAN 2012, DOI: 10.1111/j.1440-1681.2011.05656.x

  15. Mosaicism in von Hippel–Lindau disease with severe renal manifestations

    Clinical Genetics

    Volume 84, Issue 6, December 2013, Pages: 581–584, P Wu, N Zhang, X Wang, T Li, X Ning, D Bu and K Gong

    Version of Record online : 5 FEB 2013, DOI: 10.1111/cge.12092

  16. You have free access to this content
    Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma

    Cancer

    Volume 95, Issue 1, 1 July 2002, Pages: 47–53, Hiroshi Igarashi, Mariko Esumi, Hajime Ishida and Kiyoki Okada

    Version of Record online : 28 JUN 2002, DOI: 10.1002/cncr.10635

  17. You have full text access to this Open Access content
    Sequencing of the Von Hippel-Lindau Gene in Canine Renal Carcinoma

    Journal of Veterinary Internal Medicine

    Volume 23, Issue 3, May/June 2009, Pages: 592–597, B. M. Pressler, L. E. Williams, J. A. Ramos-Vara and K. I. Anderson

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1939-1676.2009.0310.x

  18. Copy number profiling in von hippel-lindau disease renal cell carcinoma

    Genes, Chromosomes and Cancer

    Volume 50, Issue 7, July 2011, Pages: 479–488, Salwati Shuib, Wenbin Wei, Hariom Sur, Mark R. Morris, Dominic McMullan, Eleanor Rattenberry, Esther Meyer, Patrick H. Maxwell, Takeshi Kishida, Masahiro Yao, Farida Latif and Eamonn R. Maher

    Version of Record online : 31 MAR 2011, DOI: 10.1002/gcc.20865

  19. Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions

    The Journal of Pathology

    Volume 239, Issue 3, July 2016, Pages: 365–373, Anna Guinot, Holger Lehmann, Peter J Wild and Ian J Frew

    Version of Record online : 30 MAY 2016, DOI: 10.1002/path.4736

  20. You have full text access to this OnlineOpen article
    Clinical and functional properties of novel VHL mutation (X214L) consistent with Type 2A phenotype and low risk of renal cell carcinoma

    Clinical Genetics

    Volume 79, Issue 6, June 2011, Pages: 539–545, AD Sorrell, S Lee, C Stolle, J Ellenhorn, A Grix, WG Kaelin Jr and JN Weitzel

    Version of Record online : 13 MAY 2010, DOI: 10.1111/j.1399-0004.2010.01464.x